Seoul National University Bundang Hospital (SNUBH)
Carcinomatosis treatment cost in Republic of Korea runs from $23,500 to $35,500 for advanced procedures like Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Diagnostic assessments such as a consultation with an oncologist range from $27 to $100. Total expenses depend on tumor stage, the extent of cytoreductive surgery, and the clinic tier. Patients typically find 30-50% savings compared to the US. Most specialized care is concentrated in Seoul.
Typical Сarcinomatosis Treatment Costs in Republic of Korea
Bookimed Expert Insight: Advanced stage patients should prioritize centers with high surgical volumes and multidisciplinary teams. Seoul National University Hospital (SNUH) reports the highest cancer treatment statistics in the country. For complex cases, Korea University Anam Hospital offers specialized robotic cancer surgery that minimizes scarring. Patients seeking top-tier digital safety benefit from the BESTcare system at Seoul National University Bundang Hospital.
| Republic of Korea | Turkey | Austria | |
| Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | from $23,500 | from $22,500 | from $40,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Сarcinomatosis treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Сarcinomatosis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Сarcinomatosis treatment journey.
The doctor is the Director of the Yonsei Cancer Center at Yonsei University Health System in Seoul, South Korea. Specializing in the treatment of advanced gastric cancer, the doctor has extensive expertise in surgery, oncology, and gastroenterology.
The doctor has held prestigious positions such as President of the Korean Gastric Cancer Association and the International Gastric Cancer Association, and Chairman of the Board of the Korean Cancer Association and the Korean Surgical Society.
Recognized as an outstanding surgeon in gastric cancer surgery, the doctor has received numerous accolades, including the Cancer Academic Award and the Yuhan Academic Award.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
The doctor is a prominent figure in the field of surgery, holding leadership roles such as Director of the Training and Education Committee at the Korean Surgical Society and Director of the Information Technology Committee at the Korean Society of Coloproctology. The doctor also serves as Director of the Surgical Affairs Board at the Korean Society of Gastroenterology and Vice President of the Korean Association of Robotic Surgeons.
With a robust educational background from Korea University, the doctor has demonstrated surgical expertise internationally, including at the Faculty of Medicine, Chinese University of Hong Kong, and Tan Tock Seng Hospital in Singapore.
South Korean hospitals treat carcinomatosis using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Major centers in Seoul combine these with systemic chemotherapy and robotic-assisted procedures. JCI-accredited facilities focus on multimodal approaches for gastric, colorectal, and ovarian cancer metastasis to improve survival outcomes.
Bookimed Expert Insight: While most assume surgery is the first step, Korean university hospitals often prioritize 318,000+ annual oncology procedures. Data shows leading centers like Seoul National University Hospital use digital tracking to prevent errors. Choosing a facility with over 65,000 operations yearly ensures access to the highest surgical expertise for complex peritoneal cases.
Patient Consensus: Patients note that Korean surgeons carefully evaluate imaging and pathology before approving aggressive surgery. It is important to confirm if the hospital offers the CRS and HIPEC combination for your specific cancer type.
Korean tertiary centers achieve nearly 77% optimal debulking rates for peritoneal carcinomatosis. Complete cytoreduction (CC-0) occurs in 59% of cases. Median survival for colorectal metastasis reaches 35 months. Specialized facilities like Asan Medical Center perform over 65,000 surgeries annually with high technical precision.
Bookimed Expert Insight: Korea's infrastructure favors complex cases due to extreme digitalization and high patient volumes. Clinics like Seoul National University Bundang Hospital use the BESTcare system to minimize surgical errors. With Severance Hospital seeing 1.6 million outpatients annually, surgeons maintain high proficiency in cytoreduction. This surgical density directly correlates with the 77% optimal debulking rate reported in local studies.
Patient Consensus: Patients note that Korean surgeons focus heavily on complete cytoreduction as the primary predictor of survival. Recovery often involves significant fatigue and weight loss during the first few months after surgery.
Top Korean hospitals for peritoneal carcinomatosis include Asan Medical Center, Severance Hospital, and Seoul National University Hospital. These JCI-accredited facilities specialize in cytoreductive surgery combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). They consistently rank among the World's Best Hospitals by Newsweek for oncology excellence.
Bookimed Expert Insight: Data shows a clear volume-based quality trend in Seoul. Asan Medical Center manages over 10,000 daily outpatients. This massive volume allows their surgical teams to specialize exclusively in peritoneal surface malignancies. For complex HIPEC procedures, this specific repetition often leads to better surgical precision than general oncology wards.
Patient Consensus: Patients note that choosing a surgeon with high case volumes for your specific cancer type is vital. They emphasize checking if the hospital has a dedicated peritoneal malignancy team rather than just a general oncology department.
The recommended stay in the Republic of Korea for CRS and HIPEC is 14 to 21 days. This window covers complex 8-hour surgery and necessary hospitalization. You must remain until stable for long-haul travel. Most patients stay in the hospital for 10 to 14 days.
Bookimed Expert Insight: Korea's major centers like Asan Medical Center and SNUH operate at massive scale, managing thousands of patients daily. This high volume means post-surgical protocols are extremely standardized. We notice that patients often need 3 to 5 extra days in a nearby hotel after hospital discharge. This buffer ensures you are eating and walking well before a long flight.
Patient Consensus: Patients emphasize that regain of bowel function and hydration levels determines when you can actually fly. They recommend booking flexible return tickets because recovery speed varies significantly between individuals.
South Korean specialty hospitals provide English-speaking doctors and dedicated coordinators for international carcinomatosis patients. Leading centers in Seoul maintain JCI-accredited departments specifically for medical tourists. These teams handle appointment logistics, medical translations, and multidisciplinary coordination for complex treatments like HIPEC.
Bookimed Expert Insight: While top oncologists often speak English, the high volume at clinics like Asan Medical Center—serving 11,800 outpatients daily—makes the dedicated international coordinator essential. These staff members ensure your HIPEC protocol details aren't lost in translation during busy shifts. Check if your chosen clinic has JCI or GHA accreditation to guarantee these communication standards.
Patient Consensus: Patients note that while lead surgeons often have high fluency, navigating nursing care and billing requires the hospital's dedicated translation support. Most recommend confirming a personal coordinator is assigned before traveling for intensive cancer treatments.